Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
- Conditions
- First Posted Date
- 2021-05-26
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1233162
- Registration Number
- NCT04903496
- Locations
- 🇨🇳
Chengdu Big Data Association, Chengdu, China
A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide
- Conditions
- Interventions
- First Posted Date
- 2021-05-26
- Last Posted Date
- 2022-08-31
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 95
- Registration Number
- NCT04903509
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany
A Study in Healthy Men and Women to Test Whether BI 1358894 Influences the Amount of Bupropion in the Blood
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 18
- Registration Number
- NCT04899674
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany
A Study to Test Whether BI 767551 Can Prevent COVID-19 in People Who Have Been Exposed to SARS-CoV-2
- Conditions
- Interventions
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2021-11-08
- Lead Sponsor
- Boehringer Ingelheim
- Registration Number
- NCT04894474
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
- Conditions
- Interventions
- First Posted Date
- 2021-05-14
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 554
- Registration Number
- NCT04886804
- Locations
- 🇺🇸
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Precision NextGen Oncology, Beverly Hills, California, United States
🇨🇳Jilin Province Cancer Hospital, Changchun, China
A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease
- Conditions
- Interventions
- First Posted Date
- 2021-05-11
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 223
- Registration Number
- NCT04881448
- Locations
- 🇺🇸
Med-Care Research, Miami, Florida, United States
🇺🇸International Research Associates, Miami, Florida, United States
🇺🇸Tidewater Kidney Specialists, Chesapeake, Virginia, United States
A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial
- First Posted Date
- 2021-05-06
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 45
- Registration Number
- NCT04876391
- Locations
- 🇦🇺
Holdsworth House Medical Practice, Sydney, New South Wales, Australia
🇦🇺Royal Melbourne Hospital, Parkville, Victoria, Australia
🇨🇦Dr. S. K. Siddha Medicine Professional Corporation, Newmarket, Ontario, Canada
A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated
- First Posted Date
- 2021-04-29
- Last Posted Date
- 2021-12-07
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 24
- Registration Number
- NCT04866160
- Locations
- 🇩🇪
Fraunhofer ITEM, Hannover, Germany
CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia
- First Posted Date
- 2021-04-27
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 609
- Registration Number
- NCT04860830
- Locations
- 🇺🇸
Sunwise Clinical Research-Walnut Creek-70166, Walnut Creek, California, United States
🇺🇸Synexus Clinical Research-Atlanta-67262, Atlanta, Georgia, United States
🇺🇸Hassman Research Institute-Berlin-60540, Berlin, New Jersey, United States
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)
- First Posted Date
- 2021-04-15
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 620
- Registration Number
- NCT04846868
- Locations
- 🇧🇷
Hospital de Base - Fac Med de Sao Jose do Rio Preto, Sao Jose do Rio Preto, Brazil
🇧🇷BR Trials, Sao Paulo, Brazil
🇬🇷University General Hospital of Thessaloniki AHEPA, Thessaloniki, Greece